Evidence map›Paper›PMID 39064077›Full record

ReviewJournal of clinical medicine2024

The Role of Speckle Tracking Echocardiography in the Evaluation of Advanced-Heart-Failure Patients.

Luca Martini, Matteo Lisi, Maria Concetta Pastore, Francesca Maria Righini, Andrea Rubboli, Michael Y Henein, Matteo Cameli

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luca MartiniDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-7596-2963
Matteo LisiDepartment of Cardiovascular Disease, AUSL Romagna, Division of Cardiology, Ospedale S. Maria delle Croci, 48121 Ravenna, Italy.
Maria Concetta PastoreDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-7223-141X
Francesca Maria RighiniDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.
Andrea RubboliDepartment of Cardiovascular Disease, AUSL Romagna, Division of Cardiology, Ospedale S. Maria delle Croci, 48121 Ravenna, Italy.
Michael Y HeneinInstitute of Public Health and Clinical Medicine, Umeå University, 90187 Umeå, Sweden.ORCID 0000-0002-6089-5614
Matteo CameliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health care is currently showing a fall in heart failure (HF) incidence and prevalence, particularly in developed countries, but with only a subset receiving appropriate therapy to protect the heart against maladaptive processes such as fibrosis and hypertrophy. Appropriate markers of advanced HF remain unidentified, which would help in choosing the most suitable therapy and avoid major compliance problems. Speckle tracking echocardiography (STE) is a good choice, being a non-invasive imaging technique which is able to assess cardiac deformation in a variety of conditions. Several multicenter studies and meta-analyses have demonstrated the clinical application and accuracy of STE in early and late stages of HF, as well as its association with both left ventricular (LV) filling pressures and myocardial oxygen consumption. Furthermore, STE assists in assessing right ventricular free-wall longitudinal strain (RVFWLS), which is a solid predictor of right ventricle failure (RVF) following LV assist device (LVAD) implantation. However, STE is known for its limitations; despite these, it has been shown to explain symptoms and signs and also to be an accurate prognosticator. The aim of this review is to examine the advantages of STE in the early evaluation of myocardial dysfunction and its correlation with right heart catheterization (RHC) parameters, which should have significant clinical relevance in the management of HF patients.

Indexed as

heart catheterizationheart failuremyocardial fibrosismyocardial oxygen consumptionspeckle tracking echocardiography

Identifiers

PMID39064077
PMCPMC11277875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.